Canada Pension Plan Investment Board’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-71,400	Closed	-$888K	–	1183
2016 Q4	$888K	Sell	71,400 -8,900	-11%	-$107K	﹤0.01%	785
2016 Q3	$1.1M	Buy	80,300 +59,400	+284%	+$596K	﹤0.01%	780
2016 Q2	$154K	Sell	20,900 -25,100	-55%	-$188K	﹤0.01%	972
2016 Q1	$294K	Sell	46,000 -19,800	-30%	-$111K	﹤0.01%	968
2015 Q4	$411K	Buy	+65,800	New	+$432K	﹤0.01%	933

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Canada Pension Plan Investment Board's ARIA Position: Q1 2017 in Review

Canada Pension Plan Investment Board sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 71,400 shares — an estimated $888K sold.

Canada Pension Plan Investment Board first reported a position in ARIA in Q4 2015 and held it in 5 quarters. The position peaked at $1.1M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Canada Pension Plan Investment Board reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Canada Pension Plan Investment Board sold 71,400 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $888K.
Canada Pension Plan Investment Board first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 5 quarters.
Canada Pension Plan Investment Board's Ariad Pharmaceuticals Inc position peaked at $1.1M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2017, filed 28 Apr 2017.